content

Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production

Rigenerand SRL, the biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology, announces it...

Kodak announces initiative to create Kodak Pharmaceuticals

Eastman Kodak Company received a $765 million loan from the United States International Development Finance Corporation (DFC) to support the launch of Kodak Pharmaceuticals,...

CRYOPORT Partners with MEDIPAL HOLDINGS to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market

Cryoport, Inc., a global leader in life sciences supply chain solutions, and MEDIPAL HOLDINGS CORPORATION, Japan's leading pharma wholesaler and distributor announced a multi-year...

Partner Therapeutics Wins $35M DoD Contract for Leukine in COVID-19

Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, anounced a $35 million milestone-based Other Transaction Agreement (OTA) with the U.S. Department of Defense (DOD)...

SEKISUI Diagnostics Invests ยฃ14.4 Million in cGMP Biopharma CDMO Capacity

Sekisui announces the decision to invest ยฃ14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in...

Thermo Fisher Expands Model Options for SampleManager LIMS

Thermo Fisher Scientific has expanded deployment model options for SampleManager LIMS software, offering laboratories support of the software deployment in the Amazon Web Services...

Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read